VZV Prophylaxis in Myeloma — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Oral aciclovir or valaciclovir prophylaxis during treatment
Bortezomib materially increases herpes-zoster reactivation and its UK SmPC recommends antiviral prophylaxis. Previous varicella and VZV IgG do not prevent reactivation. Recombinant zoster vaccination may be appropriate, but it does not substitute for antiviral prophylaxis during the period of bortezomib-associated risk.
Reference: Bortezomib SmPC: https://www.medicines.org.uk/emc/product/10201/smpc